Catalin Loghin MD
Echocardiography, Nuclear Cardiology, Cardiothoracic Imaging, Non-Invasive Cardiology
Professor, Internal Medicine, Cardiology, University of Texas Medical School, Houston
Join to view full profile
6410 Fannin StHouston, TX 77030
Phone+1 832-325-7211
Fax+1 713-512-2245
Dr. Loghin is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Catalin Loghin is a cardiologist based in Houston, TX, with subspecialties in echocardiography, nuclear cardiology, cardiothoracic imaging, and non-invasive cardiology. He completed his fellowship in cardiovascular disease and residency in internal medicine at the University of Texas Health Science Center at Houston. Dr. Loghin is experienced in general cardiology, hypertrophic cardiomyopathy, echocardiography, nuclear cardiology, and thoracic aortic aneurysm. He has authored several publications, including those on myocardial infarction and tricuspid valve surgery, with varying citation counts. Dr. Loghin has received multiple CMS Meaningful Use Certifications for his work with Allscripts Enterprise EHR systems.
Clinical Expertise
- Advanced cardiac imaging, Echocardiography, Nuclear cardiology, General cardiology, Hypertrophic cardiomyopathy, Thoracic aortic aneurysm, Internal medicine, Cardiac surgery anesthesiology, Cardiology
Education & Training
University of Texas Health Science Center at HoustonFellowship, Cardiovascular Disease, 2001 - 2004- University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1997 - 1999
University of Medicine and Pharmacy ‘Gr T Popa” Iasi Class of 1985
Certifications & Licensure
TX State Medical License 2001 - 2028
American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Allscripts Enterprise EHR, Allscripts, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise E HR, Allscripts, 2012, 2014-2017
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- 1 citationsLeft internal mammary artery to great cardiac vein fistula: innocent bystander or guilty as charged?Katia Bravo-Jaimes, Catalin Loghin, Salman Arain, Nils P. Johnson
Coronary Artery Disease. 2021-06-01 - 115 citationsA Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN...Roberto Bolli, Raul D. Mitrani, Joshua M. Hare, Carl J. Pepine, Emerson C. Perin
European Journal of Heart Failure. 2021-04-01 - 38 citationsAllogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients: The CCTRN SENECA TrialRoberto Bolli, Emerson C. Perin, James T. Willerson, Phillip C. Yang, Jay H. Traverse
JACC. Cardiooncology. 2020-11-01
Press Mentions
- Transcatheter Heart Valve Handbook: A Surgeons' and Interventional Council ReviewDecember 7th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
